Adding low‐dose gemtuzumab ozogamicin to fludarabine, Ara‐C and idarubicin (MY‐FLAI) may improve disease‐free and overall survival in elderly patients with non …

M Clavio, L Vignolo, A Albarello… - British journal of …, 2007 - Wiley Online Library
We report the final results of a prospective multi‐centre trial testing the combination of
chemotherapy (fludarabine, cytosine arabinoside and idarubicin; FLAI) followed by low …
被引用次数：48 相关文章

[引用][C] Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with …

M CLAVIO - Br J Haematol., 2007 - cir.nii.ac.jp
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may
improve disease-free and overall survival in elderly patients with non-M3 acute myeloid …

Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non …

M Clavio, L Vignolo, A Albarello… - British Journal of …, 2007 - search.ebscohost.com
We report the final results of a prospective multi-centre trial testing the combination of
chemotherapy (fludarabine, cytosine arabinoside and idarubicin; FLAI) followed by low-dose …

[引用][C] Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with …

M CLAVIO, L VIGNOLO, E BALLEARI… - British journal of …, 2007 - pascal-francis.inist.fr
Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI)
may improve disease-free and overall survival in elderly patients with non-M3 acute …

Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non …

M Clavio, L Vignolo, A Albarello… - British journal of …, 2007 - pubmed.ncbi.nlm.nih.gov
We report the final results of a prospective multi-centre trial testing the combination of
chemotherapy (fludarabine, cytosine arabinoside and idarubicin; FLAI) followed by low-dose …

Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with non …

M Clavio, L Vignolo, A Albarello, R Varaldo… - British Journal of …, 2007 - europepmc.org
We report the final results of a prospective multi-centre trial testing the combination of
chemotherapy (fludarabine, cytosine arabinoside and idarubicin; FLAI) followed by low-dose …

[引用][C] Adding low dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with …

M CLAVIO - Br J Haematol., 2007 - cir.nii.ac.jp
Adding low dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may
improve disease-free and overall survival in elderly patients with non-M3 acute myeloid …

[引用][C] Adding low-dose gemtuzumab ozogamicin to fludarabine, Ara-C and idarubicin (MY-FLAI) may improve disease-free and overall survival in elderly patients with …

M CLAVIO, L VIGNOLO, A ALBARELLO… - British journal of …, 2007 - Blackwell